クラストリディアコラーゲナゼに対する高い選択性を持つ強力な阻害剤の発見
Esther Schönauer1, Andreas M Kany2, Jörg Haupenthal2
1Division of Structural Biology, Department of Molecular Biology, University of Salzburg , Billrothstrasse 11, 5020 Salzburg, Austria.
Journal of the American Chemical Society
|August 19, 2017
まとめ
研究者らは細菌のコロラゲナーゼを標的とした 新種の阻害剤を開発しました これらの化合物は高い選択性を示し,ヒトマトリックス金属タンパク質酶 (MMPs) を節約し,微生物感染症に対する有望な治療戦略を提供します.
科学分野:
- 生物化学
- 微生物学
- 薬物の発見
背景:
- バクテリアのコラーゲナゼは,微生物感染における重要な毒性因子です.
- ヒトマトリックス金属タンパク質酵素 (MMPs) を阻害する,以前の阻害剤は選択性が欠けている.
研究 の 目的:
- バクテリアのコラーゲナゼの選択的阻害剤を発見するために
- 微生物感染に対する 治療薬の開発
主な方法:
- 表面プラズモンの共鳴によるスクリーニング
- 酵素阻害検査
- 阻害剤-標的複合体の結晶構造分析
主要な成果:
- 特定されたN- アリルメルカプトアセタミド阻害剤は,Clostridium histolyticumコラーゲナゼH (ColH) に対して微細な親和性を有する.
- 阻害剤は同種の細菌のコラーゲナゼ (ColG,ColT,ColQ1) を効果的に阻害した.
- 人間のMMPに対して軽微な活性を示し,1000倍以上の選択性を示した.
- 結晶の構造は 固有の非プリム結合モードを示した.
結論:
- 選択的細菌コラーゲネーゼ阻害剤の新型骨組みが発見されました
- プリムされていない結合モードは,広範囲の抗菌剤を開発するための戦略を提供します.
- これらの発見は 微生物感染に対する新しい治療法への道を開きます
関連する概念動画
Enzyme Inhibition
72.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
72.4K
Enzymes
68.9K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
68.9K
Drug-Receptor Bonds
4.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
4.8K
Dose-Response Relationship: Selectivity and Specificity
10.2K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.2K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.8K


